BDBM50631397 CHEMBL5432402

SMILES COC[C@@H](CC(C)C)NC1=N\C(=C/c2ccc3scnc3c2)C(=O)N1

InChI Key InChIKey=YOSRIYYLHDRWBY-UHFFFAOYSA-N

Data  29 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 29 hits for monomerid = 50631397   

TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human DYRK1A assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetTribbles homolog 2(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human TRB2 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetSerine/threonine-protein kinase TAO3(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human TAO3 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetSerine/threonine-protein kinase TAO2(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human TAO2 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetSerine/threonine-protein kinase TAO1(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human TAO1 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetTranscription initiation factor TFIID subunit 1-like(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human TAF1L assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetcGMP-dependent protein kinase 2(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human PRKG2 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetHomeodomain-interacting protein kinase 4(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human HIPK4 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetHomeodomain-interacting protein kinase 3(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human HIPK3 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetHomeodomain-interacting protein kinase 2(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human HIPK2 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetHomeodomain-interacting protein kinase 1(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human HIPK1 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetSerine/threonine-protein kinase haspin(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human HASPIN assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity tyrosine-phosphorylation-regulated kinase 3(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human DYRK3 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity tyrosine-phosphorylation-regulated kinase 2(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human DYRK2 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1B(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human DYRK1B assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK1(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human CLK1 assessed as incorporation of 33Pi using [gamma-33P]-ATP measured after 60 mins by microplate scintillation counting based ra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetMyotonin-protein kinase(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human DMPK assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK4(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human CLK4 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK3(Homo sapiens)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human CLK3 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK2(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human CLK2 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK1(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human CLK1 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetCyclin-dependent kinase-like 5(Homo sapiens)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human CDKL5 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetCyclin-dependent kinase-like 4(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human CDKL4 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetCyclin-dependent kinase-like 3(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human CDKL3 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetCyclin-dependent kinase-like 2(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human CDKL2 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetCyclin-dependent kinase-like 1(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human CDKL1 assessed as remaining activity by eurofins-cerep kinase profiler analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1B(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human DYRK1B assessed as incorporation of 33Pi using [gamma-33P]-ATP measured after 60 mins by microplate scintillation counting based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity tyrosine-phosphorylation-regulated kinase 1A(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human DYRK1A assessed as incorporation of 33Pi using [gamma-33P]-ATP measured after 60 mins by microplate scintillation counting based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed
TargetDual specificity protein kinase CLK4(Human)
Perha Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50631397(CHEMBL5432402)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of human CLK4 assessed as incorporation of 33Pi using [gamma-33P]-ATP measured after 60 mins by microplate scintillation counting based ra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/21/2024
Entry Details
PubMed